The prospective IQ-CSRC trial: A prototype early clinical proarrhythmia assessment investigation for replacing the ICH E14 thorough QTc (TQT) study.

MLA

Cavero, Icilio, et al. “The Prospective IQ-CSRC Trial: A Prototype Early Clinical Proarrhythmia Assessment Investigation for Replacing the ICH E14 Thorough QTc (TQT) Study.” Journal of Pharmacological and Toxicological Methods, vol. 80, July 2016, pp. 1–8. EBSCOhost, https://doi.org/10.1016/j.vascn.2016.02.181.

APA

Cavero, I., Holzgrefe, H., & Clements, M. (2016). The prospective IQ-CSRC trial: A prototype early clinical proarrhythmia assessment investigation for replacing the ICH E14 thorough QTc (TQT) study. Journal of Pharmacological and Toxicological Methods, 80, 1–8. https://doi.org/10.1016/j.vascn.2016.02.181

Chicago

Cavero, Icilio, Henry Holzgrefe, and Mike Clements. 2016. “The Prospective IQ-CSRC Trial: A Prototype Early Clinical Proarrhythmia Assessment Investigation for Replacing the ICH E14 Thorough QTc (TQT) Study.” Journal of Pharmacological and Toxicological Methods 80 (July): 1–8. doi:10.1016/j.vascn.2016.02.181.